Literature DB >> 30986622

Periplaneta Americana L. as a novel therapeutics accelerates wound repair and regeneration.

Long-Jian Li1, Xue-Han Xu2, Tie-Jun Yuan2, Jian Hou3, Chui-Liang Yu3, Li-Hua Peng4.   

Abstract

Kangfuxin (KFX) is the ethanol extract of Periplaneta Americana L., which has been widely used in Traditional Chinese Medicine for the treatment of injury in clinic with a long history. However, the biological influence of KFX in the different wound stages was not investigated comprehensively yet. This study aims to investigate the influence of KFX in the various wound healing activities with cellular and animal models, including the influence of KFX in 1) proliferation and cells cycle of kerationcytes and fibroblasts; 2) migration and chemotaxis of these skin cells; 3) secretion of EGF and VEGF; 4) the healing rate; 5) synthesis and deposition of different types of collagen; 6) as well as the pro-angiogenesis effect. KFX was shown to/for 1) promote the kerationcytes proliferation and regulate the cells cycle of skin fibroblasts significantly; 2) obviously stimulate the migration of kerationcytes and chemotaxis of fibroblasts; 3) the trend to promote EGF and VEGF secretion both in vitro & in vivo; 4) accelerate the wound closure, collagen synthesis and angiogenesis. KFX was demonstrated to accelerate wound healing and improve the healing quality by multiple regulation. Results of this study provide the comprehensive evidence for the application of KFX as a novel therapeutics for wound treatment.
Copyright © 2019. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Angiogenesis; Collagen synthesis; Fibroblasts; Growth factor secretion; Keratinocytes; Periplaneta Americana L.; Wound healing

Mesh:

Substances:

Year:  2019        PMID: 30986622     DOI: 10.1016/j.biopha.2019.108858

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

Review 1.  Regulation of Mitochondrial Quality Control by Natural Drugs in the Treatment of Cardiovascular Diseases: Potential and Advantages.

Authors:  Xing Chang; Wenjin Zhang; Zhenyu Zhao; Chunxia Ma; Tian Zhang; Qingyan Meng; Peizheng Yan; Lei Zhang; Yuping Zhao
Journal:  Front Cell Dev Biol       Date:  2020-12-23

2.  Potential value and chemical characterization of gut microbiota derived nitrogen containing metabolites in feces from Periplaneta americana (L.) at different growth stages.

Authors:  Weiqi Lv; Ying Cui; Gen Xue; Ziyan Wang; Lu Niu; Xin Chai; Yuefei Wang
Journal:  Sci Rep       Date:  2021-10-27       Impact factor: 4.379

3.  Microneedle Array Patch Made of Kangfuxin/Chitosan/Fucoidan Complex Enables Full-Thickness Wound Healing.

Authors:  Xixi Yu; Caixia Wang; Yuanfei Wang; Longhao Li; Xiang Gao; Tingting Zhu; Pugen An; Zhaojian Meng; Wanchun Wang; Tong Wu; Yuanping Hao
Journal:  Front Chem       Date:  2022-01-26       Impact factor: 5.221

4.  The Regulating Effect of CII-3 and Its Active Components from Periplaneta americana on M1/M2 Macrophage Polarization.

Authors:  Jinglei Xu; Yihao Che; Xinyue Liu; Chaohe Liu; Di Meng; Xiuqin Pang; Miao He; Guangming Liu; Chenggui Zhang; Dasong Yang; Huai Xiao
Journal:  Molecules       Date:  2022-07-10       Impact factor: 4.927

5.  Effects of Periplaneta americana extracts on the growth and proliferation of cutaneous interstitial cells in cutaneous-wound healing.

Authors:  Zheng Liang; Guiqi Han; Zecheng Luo; Baojie Li; Wentao Liu; Chongyang Shen
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

6.  The ethanol extract of Periplaneta Americana L. improves ulcerative colitis induced by a combination of chronic stress and TNBS in rats.

Authors:  Jing-Na Zhang; Min-Zhe Sun; Heng Liu; Han-Chao Zhang; Huai Xiao; Yu Zhao; Chenggui Zhang; Hai-Rong Zhao
Journal:  Acta Cir Bras       Date:  2022-08-12       Impact factor: 1.564

7.  Development of microparticles for oral administration of Periplaneta americana extract to treat ulcerative colitis.

Authors:  Meng Li; Hao Wu; Shuang Wang; Shengshun Wu; Jing Han; Yang Han
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.